FIELD: pharmaceutical industry.
SUBSTANCE: invention relates to the pharmaceutical industry and is a biodegradable medicinal plate for the healing of purulent wounds, containing staphylococcal bacteriophage, and/or streptococcal bacteriophage, and/or enterococcal bacteriophage, and/or proteus bacteriophage, and/or pyocyanic bacteriophage, and/or coliphage and/or klebsiella bacteriophage, methylcellulose, and/or sodium carboxymethylcellulose, and/or gelatin, and/or polyvinyl alcohol and purified water, and the components in the plates are in a certain ratio of components.
EFFECT: invention provides an increase in atraumatic and efficacy of the treatment of purulent wounds.
2 cl, 4 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
IMMUNOBIOLOGICAL BACTERICIDAL PREPARATION (VERSIONS) | 2007 |
|
RU2366708C2 |
ORAL COMPOSITION CONTAINING NONPATHOGENIC MICROORGANISMS SHOWING ABILITY TO NORMALISE INTESTINAL MICROFLORA (VERSIONS) | 2008 |
|
RU2453320C2 |
BACTERIOPHAGE COMPOSITION (VERSIONS) | 2007 |
|
RU2366437C2 |
IMMUNOBIOLOGICAL ANTIALLERGIC AGENT (VERSIONS) AND Lactobacillus acidophilus 100 "аш" PA STRAIN USED FOR PRODUCTION OF IMMUNOBIOLOGICAL ANTIALLERGIC AGENT | 2008 |
|
RU2431663C2 |
AGENT FOR SUPPURATIVE-INFLAMMATORY DISEASE TREATMENT | 1995 |
|
RU2105544C1 |
PREPARATION FOR TREATMENT OF PATIENT WITH SUPPURATIVE-INFLAMMATORY DISEASES (VARIANTS) | 1997 |
|
RU2144368C1 |
PREPARATION CONTAINING STAPHYLOCOCCAL BACTERIOPHAGE, AS PREPARATION FOR CANDIDIASIS TREATMENT | 2008 |
|
RU2377006C1 |
ANTIBACTERIAL PHARMACEUTICAL COMPOSITION FOR ORAL USE CONTAINING BACTERIOPHAGES | 2016 |
|
RU2660355C2 |
ANTIBACTERIAL COMPOSITION FOR PREVENTION OR TREATMENT OF HOSPITAL INFECTIONS (VERSIONS), BACTERIOPHAGE STAMPS USED TO OBTAIN SUCH COMPOSITION | 2015 |
|
RU2628312C2 |
SEXTAPHAGE (PYOBACTERIOPHAGE POLYVALENT) OR BACTERIOPHAGE SALMONELLOUS PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING THEREOF | 2009 |
|
RU2410084C1 |
Authors
Dates
2019-01-16—Published
2017-08-17—Filed